Essilor - News Release: Proposed combination between Essilor and Luxottica approved in China
26 Luglio 2018 - 12:30PM
Proposed
combination between Essilor and Luxottica approved in China
PDF version of the news
release
Charenton-le-Pont, France and Milan, Italy (July 26,
2018) - Essilor (Euronext Paris: EI)
and Luxottica (MTA: LUX) announce that the antitrust regulator of
the People's Republic of China, SAMR, has approved the proposed
combination between the two companies after they made certain
commitments with regard to the conduct of their business in
China.
Essilor and Luxottica committed to
inform SAMR about their future acquisitions and also to ensure
availability of their products and services to all customers in
China on a fair basis
These commitments are fully aligned with the future
EssilorLuxottica's mission to "help people see
more, be more and live life to its fullest" and the open
business model both companies promote across the globe.
Clearance from Chinese authority
was the last condition precedent to the closing of the transaction
and paves the way for the combination to be finalized. The two
companies are also progressing with their discussions with the
Turkish antitrust authority and expect the closing of the
transaction at the end of the third quarter.
CONTACTS
ESSILOR
Investor Relations
Véronique Gillet
Tel.: +33 (0)1 49 77 42 16
Corporate Communications and
Media Relations
Maïlis Thiercelin
Tel.: +33 (0)1 49 77 45 02 |
LUXOTTICA GROUP
Investor Relations and Corporate
Communications
Alessandra Senici
Tel.: +39 (02) 8633 4870
Corporate Communications and Media
Relations
Marco Catalani
Tel.: +39 (02) 8633 4470 |
About
Essilor
Essilor International (Compagnie Générale d'Optique) ("Essilor") is
the world's leading ophthalmic optics company. Essilor designs,
manufactures and markets a wide range of lenses to improve and
protect eyesight. Its mission is to improve lives by improving
sight. To support this mission, Essilor allocates more than €200
million to research and innovation every year, in a commitment to
continuously bring new, more effective products to market. Its
flagship brands are Varilux®,
Crizal®,
Transitions®,
EyezenTM,
Xperio®, Foster
Grant®,
BolonTM and
Costa®. It also
develops and markets equipment, instruments and services for
eyecare professionals.
Essilor reported consolidated revenue of around €7.5 billion in
2017 and employs approximately 67,000 people worldwide. It has 34
plants, 481 prescription laboratories and edging facilities, as
well as 4 research and development centers around the world. For
more information, please visit www.essilor.com.
The Essilor share trades on the Euronext Paris market and is
included in the Euro Stoxx 50 and CAC 40 indices. Codes and
symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg:
EI:FP.
About Luxottica
Group
Luxottica is a leader in the design, manufacture and distribution
of fashion, luxury and sports eyewear. Its portfolio includes
proprietary brands such as Ray-Ban, Oakley, Vogue Eyewear, Persol,
Oliver Peoples and Alain Mikli, as well as licensed brands
including Giorgio Armani, Burberry, Bulgari, Chanel, Coach,
Dolce&Gabbana, Ferrari, Michael Kors, Prada, Ralph Lauren,
Tiffany & Co., Valentino and Versace. The Group's global
wholesale distribution network covers more than 150 countries and
is complemented by an extensive retail network of approximately
9,000 stores, with LensCrafters and Pearle Vision in North America,
OPSM and LensCrafters in Asia-Pacific, GMO and Óticas Carol in
Latin America, Salmoiraghi & Viganò in Italy and Sunglass Hut
worldwide. In 2017, with more than 85,000 employees, Luxottica
posted net sales of over Euro 9 billion. Additional information on
the Group is available at www.luxottica.com.
Important
Information
This press release does not constitute or form a part of any offer
or solicitation to purchase or subscribe for securities in the
United States or any other jurisdiction. Securities may not be
offered or sold in the United States unless they have been
registered under the U.S. Securities Act of 1933, as amended (the
"U.S. Securities Act"), or are exempt from registration. The
securities that may be offered in any transaction have not been and
will not be registered under the U.S. Securities Act and Essilor
does not intend to make a public offering of any such securities in
the United States.
This press release is only being distributed to and is only
directed at (i) persons who are outside the United Kingdom or (ii)
investment professionals falling within Article 19(5) of the
Financial Services and Markets Act 2000 (Financial Promotion) Order
2005 (the "Order") or (iii) high net worth companies, and other
persons to whom it may lawfully be communicated, falling within
Article 49(2)(a) to (d) of the Order (all such persons together
being referred to as "relevant persons"). The securities which are
referred to herein are only available to, and any invitation, offer
or agreement to subscribe, purchase or otherwise acquire such
securities will be engaged in only with, relevant persons. Any
person who is not a relevant person should not act or rely on this
document or any of its contents.
PDF version of the news
release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Essilor International via Globenewswire